(Q54704847)

English

Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. (English)

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

0 references

1 reference

based on heuristic

inferred from title

Francesco Buccisano

5

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

Antonella Zucchetto

8

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

Adriano Venditti

12

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

Paolo de Fabritiis

13

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

14

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

Maria Ilaria Del Principe

object named as

Maria Ilaria Del Principe

2

0 references

Giovanni Del Poeta

object named as

Giovanni Del Poeta

1

0 references

object named as

Sergio Amadori

15

0 references

Emanuele Ammatuna

6

object named as

Emanuele Ammatuna

1 reference

Europe PubMed Central

3 June 2018

Francesca Maria Rossi

4

object named as

Francesca Maria Rossi

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

10

object named as

Pietro Bulian

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

3

object named as

Luca Maurillo

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

Cristina Simotti

7

object named as

Cristina Simotti

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

Gianfranco Catalano

9

object named as

Gianfranco Catalano

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

author name string

Antonio Bruno

11

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

publication date

1 January 2010

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

Leukemia & Lymphoma

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

51

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

1

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

95-106

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL).

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Human cell-surface glycoprotein with unusual properties.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Immunohistological study of transferrin receptor expression in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Transferrin receptor expression by non-hodgkin's lymphomas. Correlation with morphologic grade and survival

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Elevated Bcl-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukaemia and are correlated with in vivo chemoresistance.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

A pilot trial of the mTOR (mammalian target of rapamycin) inhibitor RAD001 in patients with advanced B-CLL.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Clinical significance of CD38 expression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Novel surface antigen expressed on dividing cells but absent from nondividing cells

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells.

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428190903350421

21 January 2018

Identifiers

10.3109/10428190903350421

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

1 reference

Europe PubMed Central

3 June 2018

http://europepmc.org/abstract/MED/20001236

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54704847&oldid=1857530599"